...
首页> 外文期刊>Medical Physics >Prostatic edema in 125I permanent prostate implants: dynamical dosimetry taking volume changes into account.
【24h】

Prostatic edema in 125I permanent prostate implants: dynamical dosimetry taking volume changes into account.

机译:125I永久性前列腺植入物中的前列腺水肿:考虑剂量变化的动态剂量测定。

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this study is to determine the impact of edema on the dose delivered to the target volume. An evaluation of the edema characteristics was first made, and then a dynamical dosimetry algorithm was developed and used to compare its results to a standard clinical (static) dosimetry. Source positions and prostate contours extracted from 66 clinical cases on images taken at different points in time (planning, implant day, post-implant evaluation) were used, via the mean interseed distance, to characterize edema [initial increase (deltar0), half-life (tau)]. An algorithm was developed to take into account the edema by summing a time series of dose-volume histograms (DVHs) with a weight based on the fraction of the dose delivered during the time interval considered. The algorithm was then used to evaluate the impact of edema on the dosimetry of permanent implants by comparing its results to those of a standard clinical dosimetry. The volumetric study yielded results as follows: the initial prostate volume increase was found to be 1.58 (ranging from 1.15 to 2.48) and the edema half-life, approximately 30 days (range: 3 to 170 days). The dosimetric differences in D90 observed between the dynamic dosimetry and the clinical one for a single case were up to 15 Gy and depended on the edema half-life and the initial volume increase. The average edema half-life, 30 days, is about 3 times longer than the previously reported 9 days. Dosimetric differences up to 10% of the prescription dose are observed, which can lead to differences in the quality assertion of an implant. The study of individual patient edema resorption with time might be necessary to extract meaningful clinical correlation or biological parameters in permanent implants.
机译:这项研究的目的是确定水肿对递送至目标体积的剂量的影响。首先对水肿特征进行了评估,然后开发了动态剂量测定算法,并使用该算法将其结果与标准临床(静态)剂量测定法进行了比较。通过平均间隔距离,使用从不同时间点(计划,植入日,植入后评估)拍摄的66例临床病例中提取的源位置和前列腺轮廓,来表征水肿[初始增加(deltar0),一半生命(tau)]。开发了一种算法,通过将剂量-体积直方图(DVH)的时间序列与权重相加来考虑水肿,该权重基于在所考虑的时间间隔内所输送剂量的分数。然后通过将该算法的结果与标准临床剂量法的结果进行比较,将该算法用于评估水肿对永久性植入物剂量法的影响。体积研究得出以下结果:最初的前列腺体积增加为1.58(从1.15到2.48)和水肿半衰期约为30天(范围:3至170天)。动态剂量法与临床剂量法在单个病例中观察到的D90的剂量法差异高达15 Gy,并取决于浮肿的半衰期和初始体积增加。平均水肿半衰期为30天,比以前报道的9天长约3倍。观察到高达处方剂量10%的剂量学差异,这可能导致植入物质量主张的差异。为了提取有意义的临床相关性或永久植入物中的生物学参数,可能需要对随时间推移而进行的个体患者水肿吸收进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号